Can Milrinone Be a Therapeutic Alternative in Persistent Pulmonary Hypertension of the Newborn? A Case Series and Narrative Review
Milrinone may serve as a feasible adjunct or bridging therapy for PPHN when iNO is unavailable. However, its use requires careful hemodynamic and neurological monitoring, particularly in very preterm infants. Further studies are needed to confirm safety and define optimal dosing across gestational ages.
Authors
- Eliza Wasilewska (ORCID: https://orcid.org/0000-0002-5288-0586)
- Łukasz Minarowski (ORCID: https://orcid.org/0000-0002-2536-3508)
- Łukasz Osiński
- Alina Minarowska (ORCID: https://orcid.org/0000-0002-9595-0628)
- Anna Doboszyńska (ORCID: https://orcid.org/0000-0001-9817-5287)
- Sławomir Dariusz Szajda (ORCID: https://orcid.org/0000-0002-6556-5008)
- Norbert Dera (ORCID: https://orcid.org/0000-0002-9250-0517)
Institutions
- Medical University of Białystok (PL)
- University Clinical Hospital In Bialystok (PL)
- University of Computer Sciences and Economics in Olsztyn (PL)
- Postgraduate School of Molecular Medicine (PL)
- University of Warmia and Mazury in Olsztyn (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Pediatric Reports
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3390/pediatric17060116
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00